Dr. Ming Lim is joining the Hematology/Hematologic Malignancies department specializing in non-malignant hematology. She earned her medical degree at Cambridge University, England and completed her 2-year Foundation Training in the United Kingdom. She then completed residency in internal medicine at the Mayo Clinic Rochester and fellowship training in hematology and oncology at University of North Carolina at Chapel Hill. Her main interests lies in the field of hemostasis and thrombosis. Her research interest is focused on complications affecting patients with congenital bleeding disorders, specifically hemophilia patients with inhibitors.
Previously, Dr. Lim was Assistant Professor of Medicine in the Division of Hematology/Oncology at the Medical University of South Carolina from 2015-2018. There she also served as the Associate Program Director for the MUSC Hematology/Oncology Fellowship Program.
Dr. Lim is actively involved in the American Society of Hematology (ASH) and the Hemostasis and Thrombosis Research Society (HTRS). She serves as the Co-Chair for the HTRS Junior Faculty Network and is a committee member for the HTRS Trainee Workshop.